May 2, 2023 4:05 PM | 1 min read

SALT LAKE CITY, May 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it will be participating in the upcoming BofA Securities Healthcare Conference in Las Vegas, NV.

Myriad management will participate in a fireside chat on Tuesday, May 9 at 3:00 p.m. PT. A live and archived webcast of the presentation can be viewed in the investor relations section of Myriad's website at http://www.myriad.com.

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

About Myriad GeneticsMyriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit http://www.myriad.com.

The Best Report Benzinga Has Ever Produced

Massive returns are within possible within this market! For a limited time, get access to the Benzinga Insider Report, usually $47/month, for just $0.99! Discover extremely undervalued stock picks before they skyrocket! Time is running out! Act fast and secure your future wealth at this unbelievable discount!

Claim your $0.99 offer NOW!

2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

See the article here:
Myriad Genetics to Participate in BofA Securities Healthcare Conference - Myriad Genetics (NASDAQ:MYGN) - Benzinga